Results 171 to 180 of about 15,270,083 (265)
Sustaining organizational change: testing a provisional model in manufacturing companies
This paper details a study into the major factors that help to sustain major manufacturing management change initiatives over a prolonged period.
BELVEDERE, VALERIA +6 more
core
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases. [PDF]
Bousquet J +155 more
europepmc +1 more source
Using Kotter's Change Management Framework to Redesign Departmental GME Recruitment. [PDF]
Miles MC +8 more
europepmc +1 more source
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
Management of IT-enabled Change in a Public Organization in Tanzania
The implementation of Information Technology (IT) is always associated with organisational change issues and in developing countries this is even more complex due to poorer and less established IT resources and governance.
Rusu, Lazar,, Nfuka, Edephonce,
core
'Everybody's voice is important': using translational simulation as a component of change management. [PDF]
Oliver N, Twentyman K, Howie K.
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Change Management and Innovation in Graduate Medical Education. [PDF]
Caretta-Weyer HA +5 more
europepmc +1 more source
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source

